The 
Subunit of Heterotrimeric G Proteins
Interacts with RACK1 and Two Other WD Repeat Proteins*
Edward J.
Dell
,
Jennifer
Connor
,
Songhai
Chen§,
Elizabeth G.
Stebbins¶,
Nikolai P.
Skiba
,
Daria
Mochly-Rosen¶, and
Heidi E.
Hamm
§
From the
Institute for Neuroscience and Department of
Molecular Pharmacology and Biological Chemistry, Northwestern
University Medical School, Chicago, Illinois 60613, the
¶ Department of Molecular Pharmacology, Stanford University
School of Medicine, Stanford, California 94305-5174, and the
§ Department of Pharmacology, Vanderbilt University Medical
Center, Nashville, Tennessee 37232-6600
Received for publication, March 21, 2002, and in revised form, September 26, 2002
 |
ABSTRACT |
A yeast two-hybrid approach was used to discern
possible new effectors for the 
subunit of heterotrimeric G
proteins. Three of the clones isolated are structurally similar to
G
, each exhibiting the WD40 repeat motif. Two of these proteins, the
receptor for activated C
kinase 1 (RACK1) and the dynein intermediate chain, co-immunoprecipitate with G
using an anti-G
antibody. The
third protein, AAH20044, has no known function; however, sequence
analysis indicates that it is a WD40 repeat protein. Further
investigation with RACK1 shows that it not only interacts with
G
1
1 but also unexpectedly with the
transducin heterotrimer
G
t
1
1. G
t
alone does not interact, but it must contribute to the interaction
because the apparent EC50 value of RACK1 for
G
t
1
1 is 3-fold greater than that for G
1
1 (0.1 versus
0.3 µM). RACK1 is a scaffold that interacts with several
proteins, among which are activated
IIPKC and dynamin-1 (1).
IIPKC and dynamin-1 compete with G
1
1 and G
t
1
1 for interaction
with RACK1. These findings have several implications: 1) that WD40
repeat proteins may interact with each other; 2) that G
interacts
differently with RACK1 than with its other known effectors; and/or 3)
that the G protein-RACK1 complex may constitute a signaling scaffold
important for intracellular responses.
 |
INTRODUCTION |
Heterotrimeric G proteins are a family of proteins that transduce
an extracellular signal to an intracellular response via a seven
helical transmembrane G protein-coupled receptor
(GPCR).1 Upon activation, the
receptor facilitates the exchange of GDP for GTP in the G
subunit.
G
is then thought to dissociate from the G
heterodimer
allowing both complexes to individually activate a number of effectors
(2, 3). Free G
interacts with a large assortment of effector
proteins, including phospholipases (4), adenylyl cyclases (5), ion
channels (6), and G protein-coupled receptor kinases (7). There are,
however, G protein-coupled receptor responses, such as MAP kinase
activation (8-10), receptor internalization (11, 12), and organelle
transport (13-15) that are mediated through the G
subunit but
that have not been definitively linked to known G
effectors.
G
is the prototypical member of a family of proteins known as WD40
repeat proteins, which seem to function as adaptors and enzyme
regulators (16, 17). G
is the only WD40 repeat protein whose
three-dimensional structure is known, and it exhibits a toroidal bladed
-propeller structure, with each blade consisting of 4 anti-parallel
-strands (18). Because the WD repeat motif is a structural element
of the
-propeller, all of these proteins are thought to be
-propeller proteins with a variable number of blades. Furthermore,
G
subunits are known to interact with G
subunits, proteins
containing a G
-like domain (19), a pleckstrin homology domain (20),
a QXXER domain (found in adenylyl cyclases) (21), and a
domain contained within phosducin and its relatives (22). In this work
we propose that G
also interacts with certain other WD40 repeat proteins.
The dynein intermediate chain (DIC) is a WD40 repeat protein that is
part of the cytoplasmic dynein multimeric protein complex, which
consists of heavy, intermediate, light intermediate, and light chains
(23). Dynein is a retrograde microtubule motor protein that is involved
in cell division and in intracellular transport (24-26). The
involvement of dynein in these processes is dictated by its different
subunit composition (27) and by its interaction with another multimeric
protein complex, dynactin (28-30). This latter interaction occurs
through the intermediate chain of the dynein complex and through
p150-glued of the dynactin complex (28, 31, 32). The regulation of the
interaction between dynein and dynactin is not fully understood;
however, phosphorylation plays a part (33-35).
The RACKs are also WD40 repeat proteins that were originally found by
their ability to bind and to localize activated PKC (36, 37). Different
RACKs interact with different PKC isozymes, and RACK1 interacts with
IIPKC (38, 39). More recently, RACK1 has been shown to interact with
a variety of other proteins such as dynamin-1 (40), Src (41, 42), the
subunit of integrins (43, 44), p120GAP (45), PDE4D5 (46, 47), the
interferon-
receptor (48), the
-chain of interleukin-5 receptor
(49), and PTPµ (50) with some of these interactions being mutually exclusive and some being concurrent. RACK1 is now considered a scaffolding protein that allows specific multiprotein complexes to form
during different signaling events. Interestingly, four of these
proteins, PKC (51-54), dynamin-1 (11, 55), Src (9, 10), and integrins
(56), have also been linked to G protein signaling.
In this study, we used a yeast two-hybrid screen to find new
G
-interacting proteins and have isolated three proteins with the
WD40 motif: RACK1, DIC, and an unknown protein, AAH20044. We confirmed
the interaction of G
with RACK1 and DIC through co-immunoprecipitation using an anti-G
1 antibody. Further
investigation with a GST-RACK1 fusion protein and purified retinal G
proteins revealed that RACK1 not only interacts with
G
1
1 alone but also binds with an apparent
higher affinity to the heterotrimer
G
t
1
1. G
t
alone does not bind to GST-RACK1, suggesting that the interaction is
mainly through G
. This result was surprising because very few
proteins other than receptors are known to interact with the whole
heterotrimer, and most known effectors of G
bind at its G
-interacting face (57, 58). Mutational analysis of RACK1 shows that
G proteins may bind to multiple regions, including one of the
IIPKC-binding sites. Confirming this,
G
1
1 and
G
t
1
1 compete with the
binding of activated
IIPKC to RACK1. Finally, G
1
1, RACK1, and dynamin-1 do not form a
trimeric complex, and dynamin-1 competes with the binding of
G
1
1 or
G
t
1
1 to RACK1.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Recombinant dyamin-1 baculovirus was a gift from
Dr. Sandra Schmid (Scripps Institute), and pET-His-DIC1A was a gift
from Dr. Kevin Vaughan (University of Notre Dame). NIH3T3 cells were obtained from American Type Culture Collection. Transducin heterotrimer and individual
and 
subunits were purified from bovine retina as described (59).
Yeast Two-hybrid--
The Hybrid Hunter Two-hybrid System
(Invitrogen) and Matchmaker LexA Two-hybrid System
(Clontech, PT3040-1) were employed. The cloning of
cDNAs into vectors was done by standard molecular techniques.
cDNA corresponding to bovine
1 was cloned into pLexA using
EcoRI/XhoI sites, and the mouse brain library
(Clontech) was cloned into pB42AD using
EcoRI/XhoI sites. By using the
EcoRI/XhoI sites, bovine
2 was cloned into
pHybLexA/Zeo. The LexA BD (binding domain) of this plasmid was deleted
beforehand by incorporating an EcoRI site upstream of the BD
(Quick Change Mutation, Stratagene), referred to now as pHyb. The yeast
strain EGY48/pSH18-34, which has a LEU2 site integrated in
the genome and a lacZ plasmid, was employed. Transformation
of the yeast was performed as outlined in the Matchmaker LexA
Two-hybrid System User's Manual. Interaction of the proteins was
determined by the ability of the yeast to grow on leucine minus (leu
)
media and the ability to turn blue in the presence of
5-bromo-4-chloro-3-indolyl
-D-galactopyranoside (X-gal).
The "positive" clones were sequenced, and a BLASTN search was
performed to determine the identity of the proteins (74).
Expression and Purification of Cytoplasmic Dynein
Intermediate Chain-1A--
A 10-ml LB/amp(100 µg/ml) overnight
culture of Escherichia coli BL21 cells containing pET-DIC1A
was used to inoculate 500 ml of 2YT/amp. The culture was grown for
2.5 h (A600 = 0.6) at 37 °C and
then induced with isopropylthio-
-galactoside (IPTG) (0.5 mM) for 4 h. Cells were collected and frozen. Cells
were thawed at room temperature and resuspended in 15 ml of washing buffer (20 mM imidazole; 0.5 M NaCl; 20 mM Tris-HCl (pH 7.9); protease inhibitor cocktail (PIC)
(Amersham Biosciences); and 1% Triton X-100). Cells were sonicated on
ice and then spun at 50,000 rpm for 1 h at 4 °C. Supernatants
were collected and poured over a 2.5-ml nickel-nitrilotriacetic
acid-agarose (Qiagen) column, pre-washed twice with 20 ml of washing
buffer. The resin was washed four times with 20 ml of washing buffer
and then eluted with 4 ml of elution buffer (1 M imidazole,
0.5 M NaCl, and 20 mM Tris-HCl (pH 7.9)). The
eluent was dialyzed into 40% glycerol/PBS with 1 mM
-mercaptoethanol and 20 mM phenylmethylsulfonyl
fluoride. His-DIC-1A was approximately 60% pure as determined by
SDS-PAGE/Coomassie, and calculations of concentrations used were based
on that purity.
Expression and Purification of MPB-RACK1--
A 10-ml LB/amp
(100 µg/ml) overnight culture of BL21 cells containing pMAL-RACK1 was
used to inoculate 500 ml of 2YT-amp (100 µg/ml). The culture was
grown for 3 h (OD = 0.6) at 37 °C and then induced with
IPTG (0.3 mM) for 3 h. Cells were collected and
frozen. Cells were thawed at room temperature and resuspended in 15 ml
of column buffer (10 mM Tris-HCl (pH 7.5), 200 mM NaCl, 1 mM EDTA, 1 mM
dithiothreitol, 0.5% Igepal, and protease inhibitor mixture). Cells
were sonicated on ice and then spun at 35,000 rpm for 1 h at
4 °C. Supernatants were collected and poured over a 2.0-ml amylose
resin (New England Biolabs) column, which had been pre-washed twice
with 20 ml of column buffer. Resin was washed four times with 20 ml of
column buffer, then eluted with 4 ml of elution buffer (column buffer
and 10 mM maltose), and then dialyzed into 40%
glycerol/column buffer. MBP-RACK1 was >85% pure as determined by
SDS-PAGE/Coomassie.
Expression and Purification of Dynamin-1--
Expression and
purification were carried out as described (60). Dynamin-1 was stored
in GTPase buffer (50 mM Na-HEPES (pH 7.2), 10 mM MgSO4, 1 mM EDTA, 1 mM dithiothreitol, 0.1% Tween, 0.1 mg/ml bovine serum
albumin). Dynamin-1 was >95% pure.
Immunoprecipitation with Recombinant and Purified
Proteins--
Proteins were incubated at 4 °C with constant shaking
for 30 min in a final volume of 200 µl using PBS for DIC/G
and
column buffer for MBP-RACK1/G
. 1 µg of antibody (Santa Cruz)
was added and incubated at 4 °C for 30 min, followed by the addition
of 50 µl of a 50% slurry of protein A-Sepharose (Amersham
Biosciences) and incubated at 4 °C for 30 min. The beads were washed
three times with 500 µl of either PBS + 0.1% Igepal or column buffer + 0.1% Igepal, transferred to new tubes on the third wash, boiled in
loading buffer, and resolved with SDS-PAGE (10-20%).
Immunoprecipitation with Endogenous Proteins--
NIH3T3 cells
were grown in Dulbecco's modified Eagle's medium supplemented with
10% fetal bovine serum, ampicillin (100 µg/ml), and streptomycin
(100 µg/ml). When stated, cells were serum-starved for 6 h. A
100-mm plate of cells at ~85% confluency was lysed with 1.5 ml of
RIPA buffer (100 mM Tris-HCl (pH 7.5), 1% Igepal, 0.5%
deoxycholate, 0.1% SDS, and protease inhibitor mixture) or with Triton
buffer (100 mM Tris-HCl (pH 7.5), 100 mM NaCl,
1% Triton X-100, and PIC) at 4 °C with constant rotation for 30 min. Plates were scraped, and lysates were collected and centrifuged at
14,000 rpm for 45 min at 4 °C. The supernatants were collected and
incubated with 2 µg of anti-G
antibody overnight at 4 °C with
constant shaking. The supernatants were incubated with 40 µl of a
50% slurry of protein A-Sepharose for 1 h at 4 °C with constant shaking. The resin was washed three times with buffer, transferred to new tubes on the third wash, boiled in loading buffer,
and resolved with SDS-PAGE (10-20). The Triton-insoluble pellet was
resuspended in 100 µl of PBS with 1% SDS and sonicated to disrupt
it. 10 µl was added to each lane.
Western Blot--
The gels were transferred to polyvinylidene
difluoride membranes using a semi-dry apparatus. The membranes were
blocked with a 3% milk, PBS, 1% Igepal buffer for 30 min at 4 °C,
followed by an overnight incubation with the appropriate antibody
(DIC-1A (1:1000) (gift from Prof. Kevin Vaughn, University of Notre
Dame); RACK1 (1:5000) and dynamin-1 (1:2000) (Transduction
Laboratories); G
(1:10,000) (Santa Cruz Biotechnology); G
t
(1:10,000) (gift from Prof. David Manning, University of Pennsylvania);
IIPKC (1:2000) (Santa Cruz Biotechnology)). The appropriate
secondary antibody, conjugated to horseradish peroxidase, was incubated with the membrane for 1 h at room temperature. Detection was
performed with chemiluminescence (Kirkegaard & Perry Laboratories or
Pierce) by either x-ray film or a Fluor-S Imager (Bio-Rad).
GST-RACK1 Mutations--
The mutations N1 (RACK1 amino acids
1-203), C1 (amino acids 203-317), N2 (amino acids 1-111), and C2
(amino acids 113-207) were created using standard molecular cloning
techniques. For N1 and C2, we made use of an internal BamHI
site of RACK1. The full-length RACK1 in pGEX-4T (Amersham Biosciences)
was cut with BamHI (there is a BamHI site in the
multiple cloning site of pGEX-4T), which gives a C-terminal
fragment, that was ligated into cut pGEX-4T and a pGEX-4-N-terminal
RACK1 fragment that was ligated back together. For the N2 and C2
mutants, an EcoRI site was incorporated into pGEX-4T-N1-RACK1 using Quick Change site-directed mutagenesis, which
changed alanine 112 to a glutamine. This construct was cut with
EcoRI, which gives a C2 fragment and pGEX-4-N2-RACK1
fragment because of an EcoRI site in the multiple
cloning site. The N2 fragment was ligated back onto itself, which
subsequently incorporates an extra nine amino acids at the C terminus
from the other restriction sites in the multiple cloning site.
The C2 fragment was ligated into EcoRI-digested pGEX-4T. The
correct clones were confirmed by sequencing.
GST-RACK1 and Mutant Expression--
10 ml of BL21 cells
containing pGEX4T-RACK1 or one of the mutants were grown overnight in
LB/amp (100 µg/ml) at 37 °C with shaking. 500 ml of LB/amp was
inoculated with the overnight sample, grown at 37 °C for 4 h
(A600 = 1-1.3), and then induced with
0.2 mM IPTG for 3 h. Cells were collected by
centrifugation at 2000 rpm for 10 min at 4 °C and washed once with
PBS. The cells were frozen overnight at
80 °C. The cells were
thawed on ice and resuspended in 15 ml of PBS, 1% Triton, 1 unit of
PIC, sonicated, rotated for 1 h at 4 °C, and then centrifuged
at 50,000 rpm for 1 h at 4 °C. Glycerol (50%) was added to the
Triton-soluble fraction (supernatant), and the lysates were stored at
20 °C.
GST Binding Assays--
0.5 ml of assay buffer (50 mM Tris-HCl (pH 7.4), 200 mM NaCl, 12 mM
-mercaptoethanol, and 1% polyethylene glycol) with 1 unit of PIC was added to the glycerol lysate volume to yield a final
concentration of 300 nM GST-RACK in the 200-µl assay
(protein concentration was determined by isolating all the GST-RACK1 or mutant from a 1-ml aliquot of the glycerol lysates and using a Bradford
protein assay). Glutathione-Sepharose (Amersham Biosciences), 50 µl
of a 50% slurry, was added to the diluted lysate. The mixture was
incubated for 30 min at room temperature with rotation. The resin was
washed three times with 500 µl of assay buffer. The appropriate
amount of G protein was added, and assay buffer was added to a final
volume of 200 µl. This was incubated for 30 min at room temperature,
washed three times with assay buffer, transferred to new tubes on the
third wash, boiled in loading buffer, and resolved with SDS-PAGE.
Studies with
IIPKC included an extra incubation for 30 min at room
temperature with activated
IIPKC before G protein was added
(
IIPKC was activated by incorporating phospholipid vesicles,
consisting of diacylglycerol (2 µg/ml) and phosphatidylserine (60 µg/ml), to the assay, then
IIPKC (50 nM), and then 1 mM CaCl2 as described (39)). Studies with
dynamin-1 included an extra incubation of 30 min at room temperature
after the addition of G protein.
 |
RESULTS |
Yeast Two-hybrid Screen--
Bovine G
1, fused to
the C terminus of the LexA binding domain (BD), was used as bait in a
yeast two-hybrid screen of a mouse brain library. The library consisted
of open reading frames ~1 kbp in length that were amplified from the
poly(A) tail and fused to the C terminus of a yeast activation domain
(AD). Prior to the screen, we determined that neither
LexA-G
1 without the activating domain nor
LexA-G
1 with the activation domain alone gave a positive result in the assay.
Because G
1 is normally associated with a G
subunit,
it was important to determine whether LexA-G
1 folds
properly with endogenous yeast G
. When properly folded and exposed
to trypsin, G
has only one exposed cleavage site (61). A tryptic
digest of yeast lysates expressing LexA-G
1 found that
most of the LexA-G
1 is folded properly, suggesting
assembly with yeast G
; however, there was also some misfolded
LexA-G
1 protein (not shown). Therefore, we repeated the yeast
two-hybrid assay with our positive clones in the presence of bovine
G
2 expressed from another yeast plasmid, pHyb. Under
these conditions, all of the LexA-G
1 had only one tryptic cleavage site, indicating proper assembly with bovine G
2. Those clones that were positive when
G
2 was present were further characterized.
To eliminate further false positives in the assay, we 1) confirmed the
interaction of the isolated AD proteins with LexA-G
1; 2)
determined if the isolated AD protein plus the BD alone was positive;
and 3) determined if the AD protein alone gives a positive result.
Unexpectedly, yeast with the AD protein and the LexA-BD alone grew on
the leucine minus media; however, they did not turn blue,
suggesting the promoter for LEU2 may be leaky. Table
I outlines these results for the
proteins presented here.
WD Repeat Protein--
The three clones in Table I are all WD40
repeat proteins: RACK1, DIC, and an unknown protein (AD2-61-1). The
unknown protein matches the sequence of a hypothetical protein with the
GenBankTM accession number AAH20044 but has no known
function. All of the proteins fall into the same family as G
and are
thought to exhibit the same
-propeller fold as G
(Fig.
1A). When aligned according to
their predicted WD motifs (Fig. 1B), the individual blades
and the proteins show little sequence homology, except at key positions
(highlighted in blue) as is usually seen for WD repeat
proteins. Isolating three structurally similar proteins from a screen
suggests the possibility that select WD repeat proteins may interact
with each other.

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 1.
Structure and sequence alignment of
the WD repeat proteins. A, ribbon representation of the
G 1 1 crystal structure (18) (PDB1TBG).
G 1, represented in blue, forms a coiled-coil
interaction with the N terminus of G 1. The seven
-blades of G 1, defined by a WD repeat, are
highlighted in different colors. B, the sequences for
G 1 (bovine) (RGB0B1), RACK1 (rat) (A36986), DIC-1A
(mouse) (AAC33444), and the unknown protein (mouse) are shown. They
were submitted to bmerc-www.bu.edu/bioinformatics/wdrepeat.html for
analysis to predict WD repeat -blade formations. The sequences are
aligned according to the WD repeat template (top of each blade
alignment). Highlighted in blue are the amino acids
important for hydrogen bonding and for stabilizing the toroidal
structure, with the aspartic acid (italicized) being the
most conserved residue (18). Arrows above the
template represent which amino acids form the 4 -sheets, which in
turn form each -blade. The red arrow indicates the first
-sheet of the next blade. This is at the end of the variable loop
region, which is in between each -blade. DIC has only six WD
repeats; therefore its WD7 is its C terminus.
|
|
Immunoprecipitations--
We confirmed the interaction of G
with the DIC through co-immunoprecipitations (co-IP) (Fig.
2). A bacterially expressed human
His-DIC-1A and bovine retinal G
1
1 are
shown to interact in vitro (Fig. 2A). This
interaction is further verified by showing that endogenous DIC
co-immunoprecipitates with a G
antibody from NIH3T3 cells both in
the presence and absence of serum (Fig. 2B, lanes
2 and 3, respectively).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Dynein intermediate chain
co-immunoprecipitates with G . A, in vitro
immunoprecipitates (IP) of recombinant His-DIC1A (1 µM) and bovine G 1 1 (1 µM). Lanes 1 and 2, IP using an
anti-G 1 antibody (T20); lane 3, IP with no
antibody. B, IP of endogenous DIC from NIH3T3 cells using an
anti-G antibody (T20). Lane 1, control, no
antibody; lane 2, IP from cells in serum; lane 3,
IP from serum-starved cells (no fetal bovine serum); lane 4,
RIPA-soluble fraction from cells with serum; lane 5,
RIPA-soluble fraction from serum-starved cells. All experiments were
repeated three times, unless otherwise noted.
|
|
We also confirmed the interaction of G
with RACK1 through co-IPs
(Fig. 3). A bacterially expressed rat
RACK1 fused to the maltose-binding protein (MBP) and bovine retinal
G
1
1 are shown to interact in
vitro (Fig. 3A) using two different G
antibodies (lanes 2 and 3) and a G
1 antibody
(lane 4). Again, the interaction is further verified by
showing that endogenous RACK1 co-IPs with a G
1 antibody
(T20) from NIH3T3 cells both in the presence and absence of serum (Fig.
3B, lanes 3 and 4).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
RACK1 co-immunoprecipitates with G .
A, in vitro immunoprecipitates (IP) of
recombinant MBP-RACK1 (1 µM) and bovine
G 1 1 (1 µM). Lane
1, purified MBP-RACK1 (1 µg); lanes 2 and
3, IP using two anti-G 1 antibodies T20 (C
terminus directed antibody) and M14 (N terminus directed antibody);
lane 4, IP using an anti-G 1 antibody;
lane 5, control, no antibody. B, IP of endogenous
RACK1 from NIH3T3 cells using an anti-G antibody (T20). Lane
1, purified MBP-RACK1 (0.5 µg); lane 2, control (no
G 1 1); lane 3, IP from cells in
serum; lane 4, IP from serum-starved cells; lanes
5 and 6, Triton-soluble and -insoluble fractions from
cells with serum; lanes 7 and 8, Triton-soluble
and -insoluble fractions from serum-starved cells.
|
|
RACK1 Binds to Both G
1
1 and
G
t
1
1--
Investigation
using a GST-RACK1 fusion protein revealed that not only does
G
1
1 interact with RACK1 but that
heterotrimeric G
t
1
1
interacts with it and with an apparent higher affinity (Fig.
4A, compare lanes 3 and 5 to 4 and 6). Equal amounts of GST-RACK1 were loaded in each lane (Fig. 4A, top
blot), demonstrating that the difference in affinity is not due to
unequal amounts of RACK1. Again, as shown in Fig. 4B,
G
t
1
1 has a higher affinity than G
1
1 for RACK1 (compare lanes
4 to 5); however, neither G
t-GDP
(lanes 6 and 7) nor G
t-GTP-
-S
(lane 8) interacts with RACK1. Furthermore, because
G
t is present (middle blot, lane 4) in the pull-down assay, RACK1 must interact with the
heterotrimer and not just displace G
t while binding to
G
1
1. The interaction thus likely occurs
through G
1
1; however, G
t
must contribute directly or indirectly to the interaction, because the
heterotrimer has a higher affinity.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
GST-RACK1 binds purified
G 1 1 and
G t 1 1 but not
G t alone. A, RACK1 interacts with both
G 1 1 and
G t 1 1. Lanes 1 and 2 (control), GST alone with
G 1 1 and
G t 1 1; lanes 3 and 5, GST-RACK1 with G 1 1, 0.5 and 1.0 µM; lanes 4 and 6,
GST-RACK1 with G t 1 1, 0.5 and 1.0 µM. The final concentration of GST and GST-RACK1
is estimated at 0.3 µM. Experiments were repeated five
times. B, RACK1 does not interact with G t-GDP
or G t-GTP- -S. Lane 1, purified
G t 1 1; lanes 2 and 3 (control), GST alone with
G 1 1 and
G t 1 1; lane 4,
GST-RACK1 with G t 1 1, 1.0 µM; lane 5, GST-RACK1 with
G 1 1, 1.0 µM; lanes
6 and 7, GST-RACK1 with G t-GDP, 0.5 and
1.0 µM; lane 8, GST-RACK1 with
G t-GTP S, 1.0 µM. The final
concentration of GST and GST-RACK1 is estimated at 0.3 µM. C, graph and blot depicting increasing
amounts of G t 1 1 and
G 1 1 bound to a fixed amount of GST-RACK1.
GST-RACK1 (0.3 µM) was incubated with increasing amounts
G 1 1 or
G t 1 1. Lanes
1-5 and 6-10 are
G t 1 1 and
G 1 1, respectively, at concentrations of
0.1, 0.2, 0.4, 0.8, and 1.0 µM. The densitometry
measurements (using Scion Image) are plotted as a percentage of maximum
bound, with the maximum bound being the measurement at 1.0 µM and normalized to 100%. The measurements are graphed
with GraphPad Prism software and using the equation parameters for a
sigmoidal dose-response curve (variable slope) with an
n = 2.
|
|
Apparent EC50 values of
G
t
1
1 and
G
1
1 for GST-RACK1 were determined by
binding increasing amounts of each protein to a fixed amount of
GST-RACK1 (Fig. 4C, blot). The amount of
G
t
1
1 or
G
1
1 pulled down was measured by
densitometry and plotted as a percentage of maximum bound
versus concentration (Fig. 4C, graph).
As seen in the graph, 50% of
G
t
1
1 binds at a
concentration of 0.1 µM, whereas 50% of
G
1
1 binds at a concentration of 0.3 µM.
G Proteins Compete with Activated
IIPKC for Binding to
RACK1--
RACK1 was originally isolated by its ability to interact
with activated
IIPKC (62). We wanted to determine whether
G
t
1
1 or
G
1
1 binds to RACK1 concurrently or
competitively with activated
IIPKC. Fig.
5A demonstrates that
increasing the concentration of G
1
1,
either as heterodimer or as heterotrimer, decreases the amount of
activated
IIPKC bound to GST-RACK1 and increases the amount of
G
1
1 bound (compare lanes 1 to
2 for G
1
1 and lanes
3 and 4 for
G
t
1
1). Because there was a
reduction of
IIPKC and an increase in
G
1
1, the binding seemed to be
competitive. However, higher concentrations of
G
1
1 (1 µM) never completely inhibited the binding of
IIPKC to GST-RACK1 (not shown).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
G t 1 1
and
G 1 1
compete with activated IIPKC for binding to
RACK1. A fixed amount of GST-RACK1 (0.3 µM) was
incubated with a fixed amount of activated IIPKC (0.05 µM), followed by increasing amounts of
G 1 1 or
G t 1 1. Lanes 1 and 2 are 0.1 and 0.4 µM
G 1 1; and lanes 3 and
4 are 0.1 and 0.4 µM
G t 1 1. As more G protein is
added, there is an increase in G 1 1
binding and a decrease in activated IIPKC binding to RACK1.
|
|
Because the interaction seemed to be competitive but not mutually
exclusive, we wanted to narrow down the site on RACK1 that interacts
with G
. We constructed N-terminal (N1) and C-terminal (C1)
mutants of RACK1 expressed as GST fusion proteins (Fig.
6A). Analysis of these two
mutants (Fig. 6B) shows that G proteins interact with
N1-RACK1 (lanes 6 and 7) and not with C1-RACK1
(lanes 8 and 9). To further define the
interaction region on N1-RACK1, we divided this segment into two halves
(Fig. 6A). However, this failed to narrow down one specific
G
-binding site, because both truncation mutants, N2-RACK1 and
C2-RACK1, bind G
t
1
1 and
G
1
1 (Fig. 6B, lanes
10 and 11). This result suggests that
G
1
1 has multiple sites of interaction on
RACK1, with probable overlap on one of the
IIPKC-binding sites (63).
This may explain why G
1
1 competes with
activated
IIPKC but never fully inhibits its binding to RACK1.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
G has
multiple binding sites on RACK1. A, diagram depicting
GST-RACK1 and its mutations. The mutations are as follows:
N1-RACK1, amino acids 1-207; C1-RACK1, 207-313;
N2-RACK1, 1-111; and C2-RACK1, 113-207. The
hatched areas are the points of interaction with IIPKC.
B, to determine which mutants bind G proteins, GST-RACK1 or
its mutants were incubated with
G t 1 1 or
G 1 1, upper panel and
lower panel, respectively. Lanes 2-9 have two
concentrations of G t 1 1,
0.5 and 1.0 µM, or of G 1 1,
1.0 and 2.0 µM. Lane 1, purified G protein;
lanes 2 and 3, control using GST; lanes
4 and 5, GST-RACK1 (0.25 µM); lanes
6 and 7, GST-N1-RACK1 (0.5 µM);
lanes 8 and 9, GST-C1-RACK1 (0.5 µM). Lanes 10 and 11 are
GST-N2-RACK1 (0.5 µM) and GST-C2-RACK1 (0.5 µM), respectively, with 0.5 µM
G t 1 1 or 1.0 µM G 1 1.
|
|
G
t
1
1 and
G
1
1 Differ in Their Interaction with
RACK1 When Dynamin-1 Is Present--
A second RACK1 interacting
protein is dynamin-1 (40), which also interacts with G
(11, 55).
We wanted to determine whether
G
t
1
1 or
G
1
1 bind to RACK1 concurrently or
competitively with dynamin-1. Keeping GST-RACK1 and
G
1
1 or
G
t
1
1 constant, while
increasing the concentration of dynamin-1
(Fig. 7), showed distinctively different
results between G
t
1
1
(lanes 2-6) and G
1
1
(lanes 7-11). For
G
t
1
1, dynamin-1 excluded
it from GST-RACK1 but not until its highest concentration (lane
6), demonstrating competition. For
G
1
1, the lowest concentration of
dynamin-1 excluded it from GST-RACK1 (lane 8).
Interestingly, very little dynamin-1 bound to GST-RACK1 at its lower
concentrations (lanes 8 and 9); however, there is
dynamin-1 bound at its higher concentrations (lanes 10 and
11). This also demonstrates competition, but the dynamics of
the interaction are more complex because
G
1
1 also interacts with dynamin-1 (11,
55). A probable explanation for these results is that all of the
proteins compete for binding to each other but that the affinity of
G
1
1 and dynamin-1 is higher than that of
RACK1 for either protein. At the lower concentrations of dynamin-1, it
was all bound to the G
1
1, preventing it
or G
1
1 from binding to GST-RACK1. At the
higher concentrations of dynamin-1, there was an excess of protein that
was not bound to G
1
1 and so in turn
bound GST-RACK1.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 7.
RACK1, G proteins, and dynamin-1 do not bind
concurrently. To determine whether there is competition with
dynamin-1, a fixed amount of GST-RACK1 (0.3 µM) was
incubated with a fixed amount of
G t 1 1 (0.2 µM), lanes 2-6, or
G 1 1 (0.4 µM), lanes
7-11, followed by incubation with increasing amounts of dynamin-1
(0, 0.125, 0.25, 0.5, and 1.0 µM), lanes 2-6
and 7-11. Lane 1 is purified dynamin-1 (1.0 µM) and G t 1 1
(0.2 µM). The binding of
G t 1 1 to RACK1 was not
inhibited until the highest concentration of dynamin-1, whereas the
binding of G 1 1 was inhibited at the
lowest concentration of dynamin-1. Experiments were repeated four
times.
|
|
 |
DISCUSSION |
WD Repeat Motif--
A recurrent theme in signaling processes has
emerged, that of multimeric protein complexes with activators and
effectors bound together by adaptors in precise spatial arrangement to
ensure proper cellular signaling. The association of multiple WD repeat proteins with G
from a yeast two-hybrid screen suggests a new interaction motif. One could easily imagine WD repeat proteins as the
scaffold for such a multimeric protein complex. G
was the first WD
repeat protein crystallized, and because the WD repeat is a structural
element for the
-propeller, all WD repeat proteins are thought to
exhibit the same toroidal shape as G
(Fig. 1A) with
variations on the number of repeats (16, 17). When trying to visualize
the interaction of two WD repeat proteins with each other, it would be
interesting to consider if it occurs top-to-bottom, side-to-side,
side-to-top, or side-to-bottom. Structural studies of WD repeat protein
complexes would help us understand the basis of their interaction.
Interaction between G
and DIC--
The evidence presented
for this interaction consists of a yeast two-hybrid interaction and
co-IPs. Any discussion of its function must be based on the known
literature. Furthermore, the interaction (Fig. 2) is weak when compared
with the interaction of G
with RACK1 (Fig. 3) and may not be
absolute. However, there may be binding cofactors that facilitate the
interaction, i.e. when DIC is in complex with its light and
heavy chains. This has precedent in the interaction of G
with the
exocytotic machinery; G
has a higher affinity for the complex
than the individual components (64).
Several interesting findings stand out in the literature that could
lead to possible functional roles of the G
and DIC interaction. One is the finding that tctex-1, a dynein light chain, interacts with
the C terminus of rhodopsin, a GPCR (27, 65), which is shown to be
important for apical transport. The light chains of dynein interact
directly with the intermediate chains (23), which raises the question:
do G proteins help regulate apical transport through the interaction of
G
with DIC? Another scenario could have G proteins helping to
define the intracellular role of dynein by regulating its interaction
with dynactin (28, 31, 32). This interaction is regulated by
phosphorylation (34, 35); however, it has not been clearly defined
(24). Could G proteins help provide specificity for the involvement of
dynein in cell division and/or intracellular transport, cellular
processes that also involve heterotrimeric G proteins (14, 15, 66-68)? The literature poses several other avenues that could be pursued, and
it will be interesting to discern the functional role(s) of this interaction.
Interaction between G
and RACK1--
At first, our interest
in this interaction was initiated by a possible connection to undefined
G
-mediated responses. RACK1 interacts with both activated
IIPKC (37) and dynamin-1 (40), two proteins that are also linked to
heterotrimeric G proteins.
IIPKC is a serine/threonine kinase
activated downstream of phospholipase C (69) and subsequently
heterotrimeric G proteins (70). PKCs are important second messengers
(71) with many substrates, among which are the G
subunits i, z, 12, and 16 (51-54). Phosphorylation of the N terminus of G
prevents its
re-association with the G
subunit, possibly prolonging signaling
through both subunits. Dynamin-1 is a large GTPase involved in
clathrin-coated receptor endocytosis (72) and more recently has been
linked to the MAP kinase pathway (73). Interestingly, RACK1 and G
have opposite effects on dynamin-1: G
inhibits its GTPase
activity (55), and RACK1 increases it (40). These literature findings
suggest that there may be a dynamic interaction between these proteins leading to an intracellular response such as signal attenuation, MAP
kinase activation, and/or receptor endocytosis.
The interaction of RACK1 with G
was confirmed through co-IPs
(Fig. 3). Subsequent studies using GST-RACK1 shows that it not only
interacts with G
1
1 alone but also in the
heterotrimeric form, G
t
1
1,
and with an apparent higher affinity (Fig. 4). This was very surprising
for the following two reasons: 1) very few proteins, other than
receptors, interact with the whole heterotrimer (2); and 2) all known
G
effectors bind to its G
-interacting face (57, 58). RACK1
does not interact with G
t alone; however, the G
subunit must contribute to the interaction because the heterotrimer has
a 3-fold higher affinity than the heterodimer for RACK1 (compare
EC50, Fig. 4C). G
t could
stabilize a conformation of G
1
1 that
binds better to RACK1 or G
t could participate in the
interaction but not with high enough affinity that it can bind RACK1
alone. Structural studies are needed to determine the involvement of
G
t in the interaction.
To discern a function of this interaction, we first explored the
involvement of activated
IIPKC (Fig. 5). Both
G
1
1 and G
t
1
1 compete with the
binding of activated
IIPKC to GST-RACK1 but do not entirely block
the interaction. Mutational analysis of RACK1 (Fig. 6) suggests that
G
1
1 has multiple RACK1-binding sites,
with probable overlap on one of the
IIPKC-binding sites. This could
cause competition with
IIPKC binding to RACK1 but not full exclusion.
Extending our studies to dynamin-1 (Fig. 7), we found that it competes
with the binding of G
t
1
1
to RACK1 but not until its highest concentration (1 µM).
There is also a competition between dynamin-1, RACK1, and
G
1
1; however, it is more dynamic because
all three proteins can interact with each other. Dynamin-1 competes
with the binding of RACK1 to G
1
1 in a way
that suggests the affinity of G
1
1 and
dynamin-1 is higher than that of RACK1 and dynamin-1 or that of RACK1
and G
1
1.
Implications for G Protein Signaling--
The importance of the
interaction of G
with RACK1 still remains to be determined;
however, one interesting scenario concerns the localization of RACK1 to
the membrane. RACK1 is found associated with the plasma membrane (1),
yet it is not known to be post-translationally modified in any way that
would promote membrane association, and it is not known to interact
with a G
-like domain-containing protein to localize it to the
membrane, such as G
(19). Interestingly, Sondek and Siderovski (19)
propose that RACK1 interacts with PDE4D5 through a G
-like domain.
Could the interaction of RACK1 with G
be its mechanism of
recruitment and association with the membrane, reminiscent of
G
and GRK2 (7)? One could imagine a G
-localized,
membrane-associated RACK1, which after stimulation of a
G
q-coupled receptor and subsequent activation of PKC,
would be in a position to help recruit activated PKC to the membrane (36). PKC would then be able to phosphorylate its desired substrates at
the membrane, which include various G
subunits (51-54).
Another approach to elucidate a role for this interaction is to
determine the effect RACK1 has on heterotrimeric G proteins. The
surprising result that RACK1 interacts with the
G
t
1
1 heterotrimer as well
as with the G
1
1 heterodimer raises
several questions. First, is the interaction of RACK1 with
heterotrimeric G proteins subunit-specific? Second, is the increase in
affinity of RACK1 for heterotrimer over heterodimer seen with other
subunits? Finally, because RACK1 interacts with the heterotrimer, does
it affect signaling from a GPCR? Preliminary experiments have shown
that RACK1 does bind to
G
1
2, with a similar affinity as
G
1
1. RACK1 also seems to interact with
other heterotrimers2; further studies will verify these
interactions and quantify their affinities for RACK1.
There still remain other questions that can be asked for defining the
functionality of this interaction. What is the importance of the
interplay with dynamin-1? Is there a connection to Src or
integrin
signaling in that both G proteins (9, 10, 56) and RACK1 (41-44) are
involved in the regulation of Src-mediated and integrin-mediated
signaling? The interaction between these two proteins has initiated
more questions than it has resolved. Nonetheless, these initial studies
have provided us with a solid foundation that could lead us to further
insight into the dynamics of cellular signaling.
 |
FOOTNOTES |
*
This work was supported by Grant EY100291 from the National
Institutes of Health (to H. E. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
615-343-3533; Fax: 615-343-1084; E-mail:
heidi.hamm@vanderbilt.edu.
Published, JBC Papers in Press, September 30, 2002, DOI 10.1074/jbc.M202755200
2
S. Chen, E. J. Dell, and H. E. Hamm,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
GPCR, G
protein-coupled receptor;
MAP, mitogen-activated protein;
co-ip, co-immunoprecipitations;
DIC, dynein intermediate chain;
RACKs, receptor for activated C kinases;
PKC, protein kinase C;
X-gal, 5-bromo-4-chloro-3-indolyl
-D-galactopyranoside;
BD, binding domain;
AD, activation domain;
IPTG, isopropylthio-
-galactoside;
PBS, phosphate-buffered saline;
MBP, maltose-binding protein;
GST, glutathione S-transferase;
GTP
S, guanosine 5'-3-O-(thio)triphosphate;
IP, immunoprecipitates.
 |
REFERENCES |
| 1.
|
Schechtman, D.,
and Mochly-Rosen, D.
(2001)
Oncogene
20,
6339-6347 |